Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain Syndrome

Launched by NAKHIA IMPEX LLC · May 30, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male and female, aged 18-65 years old ;
• • suffering from muscle strain, sprain, fall, wind and other diagnosed as myofascitis in patients with chronic back pain;
• • the pain reported by the subject should reach level 3 or higher on the digital rating scale of 0-10 ( 0 means no pain, 10 represents the strongest pain imaginable );
• • the mental state is good, and the pain level can be evaluated independently;
• • be able to cooperate with the treatment independently and sign a written consent.
• Exclusion Criteria:
• • Previous severe trauma with permanent musculoskeletal dysfunction;
• • symptomatic lumbar disc herniation with neurological deficits;
• • specific spinal diseases, including rheumatoid arthritis, ankylosing spondylitis, and osteoporosis;
• • diagnosed with mental illness;
• • agree not to sign the written consent;
• • pregnant, lactating or fertile women;
• • currently participating ( or participating in the past 30 days ) in research-based treatment or equipment trials.